In vivo localization and timing of oxygen delivery in human placenta based on BOLD MRI
Jie Luo1,2, Esra Abaci Turk1,2, Polina Golland3,4, Borjan Gagoski1, Carolina Bibbo5, Drucilla J Roberts6, Norberto Malpica7, Julian N Robinson5, Patricia Ellen Grant1, and Elfar Adalsteinsson2,3,8

1Fetal-Neonatal Neuroimaging & Developmental Science Center, Boston Children's Hospital, Harvard Medical School, Boston, MA, United States, 2Madrid-MIT M+Vision Consortium in RLE, Massachusetts Institute of Technology, Cambridge, MA, United States, 3Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA, United States, 4Computer Science and Artificial Intelligence Laboratory (CSAIL), Massachusetts Institute of Technology, Cambridge, MA, United States, 5Maternal and Fetal Medicine, Brigham and Women's Hospital, Boston, MA, United States, 6Obstetric and Perinatal Pathology, Massachusetts General Hospital, Boston, MA, United States, 7Medical Image Analysis and Biometry Laboratory, Universidad Rey Juan Carlos, Madrid, Spain, 8Harvard- MIT Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, United States

Synopsis

Clinically there is no direct measurement of oxygen delivery in placenta. In this study, we propose a method to map the timing of oxygen delivery in the human placenta in vivo. Healthy placentae show pn that agree with normal perfusion timing in response to maternal hyperoxygenation. Pathological placentas exhibit a more dispersed timing across the placenta. Better understanding of the timing in different type of pathology may be achieved by spatial correlation between placental pathology and in vivo placenta images in both healthy and pathological placenta based on BOLD signal change in response to maternal hyperoxygenation.

Purpose

Oxygen transport across the placenta is critically dependent on blood flow in the uterine and umbilical vessels, blood oxygen content and the diffusing capacity of the placenta.1 Clinically, Doppler ultrasound is used to measure umbilical artery blood flow as a surrogate of blood perfusion without direct measurement of oxygen delivery.2 Feasibility of BOLD MRI with maternal hyperoxygenation has been demonstrated both in animal and human pregnancies.3,4,5 In this study, we propose a method to map the timing of oxygen transport in both healthy and pathological placentae based on BOLD signal change in response to maternal hyperoxygenation.

Methods

Subjects: This IRB approved study enrolled five pregnancies. Three controls: no pathological findings in placenta and normal fetal outcome; and two pathological: one with placental infarct and velamentous cord insertion, and another with significant fetal vascular malperfusion reported of placenta post delivery. Acquisition: Studies were performed on a 3T Skyra scanner (Siemens Healthcare, Erlangen, Germany) using a combined 18-channel body and 12-channel spine receive arrays. BOLD imaging of the placenta in vivo was collected using single-shot gradient echo EPI sequence with matrix 110 x 110, 70~85 slices; in plane resolution 3 x 3 mm2, slice thickness 3mm, interleaved; TR = 5-7 s, TE = 30-38 ms, FA = 90°, BW = 2.3kHz/px. Total acquisition time 30 min, with alternating maternal oxygenation protocol, designed as three consecutive 10-minute episodes: initial normoxic episode (21% O2), hyperoxic episode (15 l/min), and a final normoxic episode. Processing: N4 bias field was estimated from the averaged signal in first normoxic episode, and bias field correction was applied to all time points. Intra volume motion was corrected using non-rigid group-wise registration and for inter-volume motion correction, pairwise registration was carried out with organ specific rigid and non-rigid body transformations in Elastix software.5 Outlier volumes were detected based on transformation fields and temporal signal change in each voxel, and excluded. The resulting 4D data is spatially smoothed by a Gaussian kernel, and temporally smoothed by a lowpass filter. Correlation Analysis: Temporal cross-correlations between the maternal oxygen paradigm and the BOLD signal time series in each voxel were calculated. Temporal delay (τ) between the signal and paradigm was added in the correlation analysis, and assigned as the value that yielded maximum possible correlation between the two.

Results and Discussions

The fact that neither maternal nor fetal hemoglobin in placentae is highly saturated,1 allows a big dynamic range during maternal hyperoxia for oxygen to act as a tracer to visualize its regional placental delivery. In Figure 1b-l, τ maps and correlation maps as well as baseline T2* weighted images are shown for one healthy and one pathological placenta. In the healthy placenta, the τ map exhibits a pattern that agrees with placental anatomy demonstrated in Fig1a.6 Spheres of low delay times resemble the central cavity of the placenta cotyledon, where the incoming blood through spiral artery arrives first (red color), and then disperse evenly throughout the villous tree. The distances between centers of each region are around 3cm, which fall in the range of cotyledon sizes.6 Time series of the ROIs corresponding to different delay component has been plotted. In the pathological case that was reported to have extensive avascular villi, there are large placental regions that have exceeded the detection limit of our paradigm τ > 10min, (blackened region on τ map and correlation map in figure 1f) with the total volume (300cm3) equal to approximately 30% of the entire placental volume. The histogram of τ for all cases examined are plotted in Figure 2. Further a single cotyledon in healthy case was segmented, and gave a delay time of 73 +/- 16 sec. This is in good agreement with previous estimations of the transit time from the spiral artery to the uterine vein of approximately 25s.7 The much broader dispersions of τ in the histograms reflect heterogeneous timing of oxygen delivery across different cotyledons. Better understanding of the timing in different type of pathology may be achieved by spatial correlation between placental pathology and in vivo placenta images. Finally we note that long-range temporal fluctuations are present in the time series, which might be removed with improved motion correction strategies.

Conclusion

We have demonstrated a method to map oxygen delivery timing in human placenta. Healthy placentae show t map that agree with normal perfusion timing in response to maternal hyperoxygenation. Pathological placentae exhibit increased dispersion of oxygen arrival across the placenta.

Acknowledgements

Comunidad de Madrid, the Madrid-MIT M+Vision Consortium, NIH R01 EB017337, NIH U01 HD087211.

References

1. Carter, A.M., Comprehensive Physiology 2015;5(3):1381-1403;

2. Resnik R., “Fetal growth restriction: evaluation and management” UpToDate Sept 2014;

3. Aimot-macron S., et al., Eur Radiol 2013;23:1335-1342;

4. Sørensen, A., et al. Ultrasound Obstet Gynecol 2013;42:310-314;

5. Klein, Stefan, et al. Medical Imaging, IEEE Transactions 2010;29:196-205;

6. Benirschke et al. Springer, (2006);

7. Burton G.J., et al., Placenta 2009;30:473-482.

Figures

Figure 1. Healthy placenta (b-e) and a pathological placenta (f-l) are shown in side-by-side comparison with a) illustration of normal human placental anatomy [6].; e) and l) are time series of delineated ROIs: red/blue curves are from red/blue regions in b) and f), magenta curve from the black regions

Figure 2. Histograms of t maps of whole placentae. a-c) normal placentae, d) pathological with placental infarct and velamentous cord insertion, e) pathological with extensive avascular villi, indicating significant fetal vascular malperfusion.



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
0970